Free Trial

Stevanato Group (STVN) Competitors

€20.32
+0.75 (+3.83%)
(As of 05/31/2024 08:51 PM ET)

STVN vs. NYXH, SYK, BSX, BDX, MMM, DXCM, RMD, WST, BAX, and SWAV

Should you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Nyxoah (NYXH), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), 3M (MMM), DexCom (DXCM), ResMed (RMD), West Pharmaceutical Services (WST), Baxter International (BAX), and Shockwave Medical (SWAV). These companies are all part of the "surgical & medical instruments" industry.

Stevanato Group vs.

Nyxoah (NASDAQ:NYXH) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, community ranking, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Stevanato Group has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$4.70MN/A-$46.77M-$1.64-5.74
Stevanato Group$1.17BN/A$157.62M$0.5536.95

Stevanato Group has a net margin of 12.57% compared to Stevanato Group's net margin of -843.49%. Nyxoah's return on equity of 12.61% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-843.49% -42.14% -33.55%
Stevanato Group 12.57%12.61%7.25%

Nyxoah has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Nyxoah presently has a consensus target price of $19.40, suggesting a potential upside of 106.16%. Given Stevanato Group's stronger consensus rating and higher possible upside, research analysts clearly believe Nyxoah is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Nyxoah received 4 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 66.67% of users gave Nyxoah an outperform vote while only 63.41% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
NyxoahOutperform Votes
30
66.67%
Underperform Votes
15
33.33%
Stevanato GroupOutperform Votes
26
63.41%
Underperform Votes
15
36.59%

In the previous week, Stevanato Group had 3 more articles in the media than Nyxoah. MarketBeat recorded 8 mentions for Stevanato Group and 5 mentions for Nyxoah. Stevanato Group's average media sentiment score of 0.58 beat Nyxoah's score of 0.30 indicating that Nyxoah is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nyxoah
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Stevanato Group beats Nyxoah on 8 of the 14 factors compared between the two stocks.

Get Stevanato Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STVN vs. The Competition

MetricStevanato GroupSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market CapN/A$3.89B$5.17B$17.84B
Dividend YieldN/A1.80%2.76%3.50%
P/E Ratio36.959.87115.3423.13
Price / SalesN/A70.772,386.0710.18
Price / Cash23.8048.0435.4119.14
Price / Book4.905.075.545.90
Net Income$157.62M$4.50M$106.07M$976.46M
7 Day Performance1.75%1.27%1.14%0.62%
1 Month Performance-24.21%-1.49%0.65%3.61%
1 Year Performance-28.70%-17.83%2.69%20.81%

Stevanato Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYXH
Nyxoah
2.9581 of 5 stars
$9.41
+2.6%
$19.40
+106.2%
+16.0%$0.00$4.70M-5.74146Short Interest ↓
News Coverage
Gap Up
SYK
Stryker
4.8602 of 5 stars
$340.85
+0.1%
$370.58
+8.7%
+22.4%$129.72B$20.50B38.9152,000Analyst Forecast
Positive News
BSX
Boston Scientific
4.6183 of 5 stars
$75.59
+0.8%
$76.70
+1.5%
+46.7%$110.03B$14.24B63.5248,000Analyst Forecast
Insider Selling
Short Interest ↓
BDX
Becton, Dickinson and Company
4.8913 of 5 stars
$232.04
+2.3%
$280.17
+20.7%
-6.5%$65.54B$19.37B51.1173,000Analyst Forecast
Short Interest ↓
High Trading Volume
MMM
3M
3.912 of 5 stars
$100.14
+2.0%
$108.55
+8.4%
+6.2%$54.34B$32.68B-7.8785,000Analyst Forecast
High Trading Volume
DXCM
DexCom
4.9599 of 5 stars
$118.77
+0.3%
$140.94
+18.7%
-0.7%$47.09B$3.62B76.639,600Analyst Forecast
Short Interest ↓
High Trading Volume
RMD
ResMed
4.6109 of 5 stars
$206.33
-1.4%
$202.80
-1.7%
-5.7%$30.75B$4.22B31.6910,140Analyst Revision
Positive News
High Trading Volume
WST
West Pharmaceutical Services
4.9787 of 5 stars
$331.41
+0.7%
$435.20
+31.3%
-3.0%$23.97B$2.95B43.7210,600Positive News
BAX
Baxter International
4.9428 of 5 stars
$34.11
+2.0%
$44.42
+30.2%
-17.3%$17.04B$14.81B6.5660,000Analyst Forecast
Short Interest ↓
SWAV
Shockwave Medical
4.3894 of 5 stars
$334.75
flat
$309.11
-7.7%
N/A$12.57B$730.23M78.211,468Positive News

Related Companies and Tools

This page (NYSE:STVN) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners